Back to company

ENKAM PHARMACEUTICALS ApS: Financial statements 2013

CVR: 25812921

ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -2,621,140 and a net result of DKK -3,665,105 compared with DKK -2,525,962 the year before. Equity amounted to DKK -4,730,496.

Gross Profit
-2,621,140 kr.
Profit/Loss
-3,665,105 kr.
Equity
-4,730,496 kr.
Total Assets
6,657,318 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013--2.6 mio.-3.7 mio.-4.7 mio.-
2012--1.1 mio.-2.5 mio.-3.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ENKAM PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

ENKAM PHARMACEUTICALS ApS: The 2012 annual report is outJun 8, 2013

ENKAM PHARMACEUTICALS ApS has published its annual report for 2012. Gross profit came to DKK -1,060,280, and the net result was DKK -2,525,962.

About ENKAM PHARMACEUTICALS ApS

ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 0 employees. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity amounted to DKK -1,179,474.

Other financial years